SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-027019
Filing Date
2022-09-28
Accepted
2022-09-28 16:05:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 form-defa14a.htm DEFA14A 45661
2 form-defa14a_001.jpg GRAPHIC 2865
  Complete submission text file 0001493152-22-027019.txt   50839
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37428 | Film No.: 221276077
SIC: 2834 Pharmaceutical Preparations